Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × encorafenib × 1 year × Clear all

Sponsor

Conditions

Melanoma 14 Colorectal Neoplasms 11 Colonic Neoplasms 6 Skin Neoplasms 4 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Brain Neoplasms 4 Rectal Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Thyroid Neoplasms 1 Solid Tumors 1 Skin Diseases 1 Rectal Diseases 1 Lymphatic Metastasis 1 Leukemia, Hairy Cell 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Disease Progression 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colonic Diseases 1 Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 38 Dexamethasone 31 venetoclax 28 fludarabine 27 pembrolizumab 20 pomalidomide 17 Rituximab 17 Gemcitabine 16 Lenalidomide 14 Cytarabine 14 carfilzomib 11 Nivolumab 11 fludarabine phosphate 10 Temozolomide 10 Etoposide 10 Calcium Dobesilate 10 Azacitidine 10 glofitamab 9 daratumumab 9 Injections 9 obinutuzumab 8 Cisplatin 8 ibrutinib 7 cemiplimab 7 Carboplatin 7 Capecitabine 7 Bevacizumab 7 zanubrutinib 6 selinexor 6 ruxolitinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡